The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Open accessAbstract
BACKGROUND: Colorectal cancer (CRC) is the second leading cause of cancer deaths despite the fact that detection of this cancer in early stages results in over 90% survival rate. Currently less than 45% of at-risk individuals in the US are screened regularly, exposing a need for better screening tests. We performed two case-control studies to validate a blood-based test that identifies methylated DNA in plasma from all stages of CRC. METHODOLOGY/PRINCIPAL FINDINGS: Using a PCR assay for analysis of Septin 9 (SEPT9) hypermethylation in DNA extracted from plasma, clinical performance was optimized on 354 samples (252 CRC, 102 controls) and validated in a blinded, independent study of 309 samples (126 CRC, 183 controls). 168 polyps and 411 additional disease controls were also evaluated. Based on the training study SEPT9-based classification detected 120/252 CRCs (48%) and 7/102 controls (7%). In the test study 73/126 CRCs (58%) and 18/183 control samples (10%) were positive for SEPT9 validating the training set results. Inclusion of an additional measurement replicate increased the sensitivity of the assay in the testing set to 72% (90/125 CRCs detected) while maintaining 90% specificity (19/183 for controls). Positive rates for plasmas from the other cancers (11/96) and non-cancerous conditions (41/315) were low. The rate of polyp detection (>1 cm) was approximately 20%. CONCLUSIONS/SIGNIFICANCE: Analysis of SEPT9 DNA methylation in plasma represents a straightforward, minimally invasive method to detect all stages of CRC with potential to satisfy unmet needs for increased compliance in the screening population. Further clinical testing is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686 · cited 1×
“proposed a systematic process for biomarker validation for early detection of cancer with 5 distinct phases, each phase providing increased level of evidence of marker validation [20].”
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Turnbull, B. A., & Ross, M. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033403 · Cited by 803
Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
Mandel, J. S., Church, T. R., Ederer, F., & Bond, J. H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.434 · Cited by 788
MORIKAWA, T., KATO, J., YAMAJI, Y., WADA, R., MITSUSHIMA, T., & SHIRATORI, Y. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.056 · Cited by 539
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095992 · Cited by 493
Self-citationDetection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene
Chen, W.-D., Han, Z. J., Skoletsky, J., Olson, J., Sah, J., Myeroff, L., Platzer, P., Lu, S., Dawson, D., Willis, J., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji204 · Cited by 370
The pathobiology of the septin gene family
Hall, P. A., & Russell, S. H. (2004) · The Journal of Pathology · doi:10.1002/path.1654 · Cited by 323
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota, M., Shen, L., Ohe-Toyota, M., Hamilton, S. R., Sinicrope, F. A., & Issa, J. J. (2000) · PubMed · Cited by 191
Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer
Wallner, M., Herbst, A., Behrens, A., Crispin, A., Stieber, P., Göke, B., Lamerz, R., & Kolligs, F. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1264 · Cited by 183
Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou, H., Yu, B.-M., Wang, Z., Sun, J., Cang, H., Gao, F., Li, D. H., Zhao, R., Feng, G.-G., & Yi, J. (2002) · PubMed · Cited by 179
Osaka, M., Rowley, J. D., & Zeleznik-Le, N. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6428 · Cited by 174
Frequently Methylated Tumor Suppressor Genes in Head and Neck Squamous Cell Carcinoma
Bennett, K. L., Karpenko, M., Lin, M.-T., Claus, R., Arab, K., Dyckhoff, G., Plinkert, P., Herpel, E., Smiraglia, D. J., & Plass, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6509 · Cited by 151
Leung, W. K., To, K., Man, E. P. S., Chan, M. W. Y., Bai, A. H. C., Hui, A. J., Chan, F. K. L., & Sung, J. J. �. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50412.x · Cited by 146
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka, S., Toyooka, K. O., Harada, K., Miyajima, K., Makarla, P., Sathyanarayana, U. G., Yin, J., Sato, F., Shivapurkar, N., Meltzer, S. J., et al. (2002) · PubMed · Cited by 129
Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas
Ebert, M. P. A., Model, F., Mooney, S., Hale, K., Lograsso, J., Tonnes–Priddy, L., Hoffmann, J., Csepregi, A., Röcken, C., Molnar, B. A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.034 · Cited by 128
Self-citationMultimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours
Scott, M., Hyland, P. L., McGregor, G., Hillan, K. J., Russell, S. E. H., & Hall, P. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208574 · Cited by 102
Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients
Nakayama, H., Hibi, K., Taguchi, M., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00839-4 · Cited by 101
Russell, S. E. H., McIlhatton, M. A., Burrows, J. F., Donaghy, P. G., Chanduloy, S., Petty, E. M., Kalikin, L. M., Church, S. W., McIlroy, S. P., Harkin, D. P., et al. (2000) · PubMed · Cited by 99
Do septins have a role in cancer?
Russell, S. E. H., & Hall, P. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602753 · Cited by 93
Altered expression of the septin gene, SEPT9 , in ovarian neoplasia
Burrows, J. F., Chanduloy, S., McIlhatton, M. A., Nagar, H., Yeates, K., Donaghy, P. G., Price, J., Godwin, A. K., Johnston, P. G., & Russell, S. H. (2003) · The Journal of Pathology · doi:10.1002/path.1484 · Cited by 90
High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes
Gonzalez, M. E., Peterson, E. A., Vinnedge, L. M. P., Loffreda-Wren, J. L., Kalikin, L. M., & Petty, E. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1474 · Cited by 87
Hypermethylation of the TPEF/HPP1 Gene in Primary, Metastatic Colorectal Cancers
Ebert, M. P. A., Mooney, S. H., Tonnes–Priddy, L., Lograsso, J., Hoffmann, J., Chent, J., Röcken, C., Schulz, H., Malfertheiner, P., & Lofton–Day, C. (2005) · Neoplasia · doi:10.1593/neo.05235 · Cited by 70
Self-citationTranslational control of SEPT9 isoforms is perturbed in disease
McDade, S. S., Hall, P. A., & Russell, S. E. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm003 · Cited by 65
DNA Methylation in Colorectal cancer—Impact on Screening and Therapy Monitoring Modalities?
Zitt, M., Zitt, M., & Müller, H. M. (2007) · Disease Markers · doi:10.1155/2007/891967 · Cited by 59
Fisher, J. A., Fikry, C., & Troxel, A. B. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0198 · Cited by 54
Amir, S., & Mabjeesh, N. J. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.4971 · Cited by 48
Regueiro, C. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.012 · Cited by 44
Cited by
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Epigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Metadata
- Authors
- Grützmann, R., Molnar, B., Pilarsky, C., Habermann, J. K., Schlag, P. M., Saeger, H. D., Miehlke, S., Stolz, T., Model, F., Roblick, U. J., Bruch, H.-P., Koch, R., Liebenberg, V., deVos, T., Song, X., Day, R. H., Sledziewski, A. Z., & Lofton-Day, C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-11-19
- Volume
- 3
- Issue
- 11
- Pages
- e3759
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2089050775
- Cited by
- 394
- References
- 29
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.